Skip to main content
. 2010 Jul 20;13(7):748–752. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2010.07.16

2.

含贝伐单抗不同化疗方案的对比

Comparison of different regimens with bevacizumab

Regimens Maintenance with Bev ORR (%) OS (month) PFS (month)
nab-Pax+Cb+Bev[15] No 31% 16.8 9.8
Gem+C+Bev[16] Yes 20.1% - 6.7
Pax+Cb+Bev[17] Yes 35% 12.3 6.2
Pem+Cb+Bev[18] Yes 55% 14.1 7.8